Related Experiment Videos

Ocular myasthenia gravis and Graves disease in a 10-year-old child

Ildiko H Koves1, Fergus J Cameron, Andrew J Kornberg

  • 1Department of Endocrinology and Diabetes, Royal Children's Hospital, Melbourne, Australia.

Journal of Child Neurology
|May 2, 2009
PubMed

Insights

This case report highlights the link between myasthenia gravis and Graves disease in a pediatric patient. Recognizing this association is crucial for timely diagnosis and improved outcomes in managing these autoimmune disorders.

Area of Science:

  • Endocrinology
  • Neurology
  • Pediatrics

Background:

  • Myasthenia gravis (MG) is a chronic autoimmune neuromuscular disease.
  • Graves disease is an autoimmune disorder causing hyperthyroidism.
  • The co-occurrence of MG and Graves disease presents diagnostic and therapeutic challenges.

Purpose of the Study:

  • To report a rare association between myasthenia gravis and Graves disease in a pediatric case.
  • To emphasize the importance of recognizing this dual diagnosis.
  • To discuss optimal diagnostic investigations for differentiating these conditions.

Main Methods:

  • Case presentation of a 10-year-old boy with coexisting myasthenia gravis and Graves disease.
  • Review of clinical presentation and diagnostic workup.
  • Discussion of relevant literature regarding the association and management.

Main Results:

  • The patient presented with symptoms suggestive of both myasthenia gravis and Graves disease.
  • Appropriate investigations were conducted to confirm both diagnoses.
  • The interplay between the two conditions impacted treatment strategies and prognosis.

Conclusions:

  • Early diagnosis of coexisting myasthenia gravis and Graves disease can lead to more effective treatment.
  • Resolution of myasthenia gravis symptoms is often contingent upon achieving a euthyroid state.
  • A comprehensive thyroid status review is recommended for all patients with ocular myasthenia gravis.

Related Concept Videos

Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...